Related Experiment Video
Updated: Jul 28, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
[HCV / HIV co-infection: a different perspective]
1Hospital Interzonal Gral. San Martín, Servicio de Gastroenterología, Cátedra de Gastroenterología de Posgrado, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina. ajmelnitzky@infovia.com.ar
Abstract:
The clinical significance of HCV-HIV co-infection has notoriously changed due to the introduction of new anti-retroviral therapeutic combinations against HIV infection. Their effectiveness in dramatically reducing AIDS mortality, and the corresponding increase in hospitalization and death related to liver disease. Considerations facing this new reality will have to include epidemiological aspects, pathogenetic interactions, the influence of highly active anti-retroviral therapies (HAART) on the natural history of HCV infection, including their HCV--enhanced liver toxicity, and current new strategies about therapeutic measures against HCV infection in the frame of the most recent advances in HIV therapy.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Infectious Diseases and Their Occurrence
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

